Publication | Open Access
Association between chronic hepatitis B infection and COVID-19 outcomes: A Korean nationwide cohort study
44
Citations
14
References
2021
Year
Underlying CHB and antiviral agents including tenofovir decreased susceptibility to SARS-CoV-2 infection. HBV coinfection did not increase the risk of disease severity or lead to a worse prognosis in COVID-19.
| Year | Citations | |
|---|---|---|
Page 1
Page 1